GOOG
57
-6
PYPL
52
-2
CMI
64
-3
TXT
53
-3
SPG
60
2
CCI
30
-11
MRO
50
4
VRSK
68
-12
VMC
53
-4
BMY
55
-8
COP
57
-2
LEN
50
-2
NOC
41
9
HPE
44
-2
FFIV
66
-4
BK
74
3
UAL
83
-2
ORLY
60
-5
STX
45
-4
MTB
65
-2
GOOG
57
-6
PYPL
52
-2
CMI
64
-3
TXT
53
-3
SPG
60
2
CCI
30
-11
MRO
50
4
VRSK
68
-12
VMC
53
-4
BMY
55
-8
COP
57
-2
LEN
50
-2
NOC
41
9
HPE
44
-2
FFIV
66
-4
BK
74
3
UAL
83
-2
ORLY
60
-5
STX
45
-4
MTB
65
-2
Financhill
Back

Generation Income Properties Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
21

GIPR
Generation Income Properties

Last Price:
1.79
Seasonality Move:
3.89%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
21
Generation Income Properties (GIPR) is a Sell

Is Generation Income Properties a Buy, Sell or Hold?

  • The current Generation Income Properties [GIPR] share price is $1.80. The Score for GIPR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GIPR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GIPR Stock Price Chart

What is Generation Income Properties's stock price today?

  • The Generation Income Properties share price today is $1.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GIPR is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GIPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 32.97 Sell
Chaikin Money Flow: -11987 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.9 - 2.06) Sell
Bollinger Bands (100): (1.8 - 3.2) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

GIPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.93 Sell
20-day SMA: 1.96 Sell
50-day SMA: 2.06 Sell
200-day SMA: 3.17 Sell
8-day EMA: 1.89 Sell
20-day EMA: 1.95 Sell
50-day EMA: 2.12 Sell
200-day EMA: 2.97 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Generation Income Properties Earnings Growth & GIPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.24 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Generation Income Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):